Interleukin-3 Receptor alpha Subunit
"Interleukin-3 Receptor alpha Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low affinity interleukin-3 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-3.
Descriptor ID |
D053650
|
MeSH Number(s) |
D12.776.543.750.705.852.420.340.500
|
Concept/Terms |
Interleukin-3 Receptor alpha Subunit- Interleukin-3 Receptor alpha Subunit
- Interleukin 3 Receptor alpha Subunit
- Interleukin-3 Receptor alpha Chain
- Interleukin 3 Receptor alpha Chain
- Antigens, CD123
- CD123 Antigens
- alpha-Subunit, Receptor, Interleukin-3
- CD123 Antigen
- Antigen, CD123
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-3 Receptor alpha Subunit".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-3 Receptor alpha Subunit".
This graph shows the total number of publications written about "Interleukin-3 Receptor alpha Subunit" by people in this website by year, and whether "Interleukin-3 Receptor alpha Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Interleukin-3 Receptor alpha Subunit" by people in Profiles.
-
Vadakekolathu J, Lai C, Reeder S, Church SE, Hood T, Lourdusamy A, Rettig MP, Aldoss I, Advani AS, Godwin J, Wieduwilt MJ, Arellano M, Muth J, Yau TO, Ravandi F, Sweet K, Altmann H, Foulds GA, Stölzel F, Middeke JM, Ciciarello M, Curti A, Valk PJM, Löwenberg B, Gojo I, Bornhäuser M, DiPersio JF, Davidson-Moncada JK, Rutella S. TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Adv. 2020 10 27; 4(20):5011-5024.
-
Pratap S, Zhao ZJ. Finding new lanes: Chimeric antigen receptor (CAR) T-cells for myeloid leukemia. Cancer Rep (Hoboken). 2020 04; 3(2):e1222.